Anticorps Recombinant de lapin anti-PCNA

PCNA Recombinant Antibody for WB, IHC, IHC-Autostainer, IF-P, FC (Intra), IP, ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain, rat, souris

Applications

WB, IHC, IHC-Autostainer, IF-P, FC (Intra), IP, ELISA

Conjugaison

Non conjugué

CloneNo.

240306B9

N° de cat : 81302-6-PBS

Synonymes

240306B9, Cyclin, proliferating cell nuclear antigen



Informations sur le produit

81302-6-PBS cible PCNA dans les applications de WB, IHC, IHC-Autostainer, IF-P, FC (Intra), IP, ELISA et montre une réactivité avec des échantillons Humain, rat, souris

Réactivité Humain, rat, souris
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène PCNA Protéine recombinante Ag0277
Nom complet proliferating cell nuclear antigen
Masse moléculaire calculée 29 kDa/31 kDa
Poids moléculaire observé36-38 kDa
Numéro d’acquisition GenBankBC000491
Symbole du gène PCNA
Identification du gène (NCBI) 5111
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Protein A purfication
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

Proliferating Cell Nuclear Antigen, commonly known as PCNA, is a protein that acts as a processivity factor for DNA polymerase δ in eukaryotic cells. This protein is an auxiliary protein of DNA polymerase delta and is involved in the control of eukaryotic DNA replication by increasing the polymerase's processibility during elongation of the leading strand. PCNA induces a robust stimulatory effect on the 3'-5' exonuclease and 3'-phosphodiesterase, but not apurinic-apyrimidinic (AP) endonuclease, APEX2 activities. It has to be loaded onto DNA in order to be able to stimulate APEX2. PCNA protein is highly conserved during evolution; the deduced amino acid sequences of rat and human differ by only 4 of 261 amino acids. PCNA has been used as loading control for proliferating cells. The calculated molecular weight of PCNA is 29 kDa, but modified PCNA is 36kDa (PMID: 1358458).

{{ptg:RelatedPrimaryAntibodies}}